Progression-Free Survival Not Improved with Cabazitaxel versus Topotecan in Refractory SCLC

Article Information

DOI 
http://dx.doi.org/10.1177/155989771403008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Rita Buckley
  1. Tracey L. Evans, MD
    1. Abramson Cancer Center, Philadelphia, Pennsylvania, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015700
May 2015100
Jun 2015200
Jul 2015311
Aug 2015200
Sep 2015200
Oct 2015332
Total2043

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Progression-Free Survival Not Improved with Cabazitaxel versus Topotecan in Refractory SCLC
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Respiratory Cancers
Cancer Clinical Trials
Respiratory Cancers
Cancer
Oncology Clinical Trials
Oncology